Echocardiography Clinical Trials

A listing of Echocardiography medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 39 clinical trials
FAPI Imaging Predicts Adverse Cardiac Events in Chronic Total Occlusion (FACT-2)

Inclusion CriteriaAge ≥ 18 yearsPresence of at least one untreated chronic total occlusion (CTO) lesion in a major coronary artery (diameter ≥ 2.5 mm, TIMI 0 flow for ≥ 3 months) confirmed by coronary angiography or CTCAPatient eligible for PCI and undergoing FAPI PET/CT imaging prior to interventionWritten informed consent …

  • 0 views
  • 16 Jun, 2025
Cardiac Output, Cerebral Perfusion and Cognition in Patients With Severe Aortic Valve Stenosis Undergoing Transcatheter Aortic Valve Implantation (CAPITA)  

Study design: Prospective observational study, measuring cardiac output (echocardiography), cerebral blood flow (arterial spin labelling magnetic resonance imaging) and cognitive functioning (neuropsychological test battery) prior to TAVI (<24 hours to <one week) and at 3 months follow-up.

  • 0 views
  • 11 Jan, 2023
  • 1 location
New Time Clock for ST-elevation MI Based on Biochemical Myocardial Infarction Onset Time

To assess the association of conventional ischemic time and biochemical ischemic time with infarct size; using peak hsTnI, percent ejection fraction by Echocardiography and Cardiac Magnetic Resonance imaging (CMR) based infarct volume in grams. To assess the association of conventional ischemic time and biochemical ischemic time with in-hospital and 30-days …

unstable angina
coronary artery occlusion
stemi
troponin
angina symptom
  • 0 views
  • 05 Aug, 2020
Cancer Therapy Effects on the Heart

Anthracycline chemotherapies (e.g. doxorubicin, daunorubicin) is commonly given to treat pediatric cancer, and carries a risk of cardiotoxicity. Over the long term, children who receive these therapies have an increased risk of heart failure and early cardiovascular death. However, current strategies for identifying patients who are at risk prior to …

cancer therapy
pediatric
cancer treatment
anthracycline
heart failure
  • 0 views
  • 16 Feb, 2024
  • 1 location
Dynamic Parameters in Evaluation of Fluid Responsiveness

Intravenous infusion of fluids in patients after surgery is a very important part of treatment. However, administering too much or too little fluid can lengthen the stay in the intensive care unit or even harm the patient. Therefore, fluid therapy should be tailored to the individual needs of each patient. …

coronary artery bypass graft
serum lactate
coronary artery bypass
fluid therapy
pulmonary pathology
  • 0 views
  • 16 Feb, 2024
  • 1 location
Risk of Pacing-induced Cardiomyopathy

This study will evaluate the association between right ventricular pacing and the risk of pacing-induced cardiomyopathy.

cardiomyopathy
atrioventricular block
  • 0 views
  • 16 Feb, 2024
  • 1 location
Evaluation of Long-term Incidence of Ventricular Arrhythmias in Patients With Acute Myocarditis

Myocarditis is an inflammatory disease of the heart muscle which is mostly caused by viruses, bacteria, parasites, toxic substances/drugs or by primary autoimmune mechanisms. Signs of heart failure (dyspnea, reduced resilience, tendency to edema), thoracic pain, palpitations / arrhythmias / syncope, as well as (potentially) lethal clinical conditions in the …

  • 0 views
  • 16 Feb, 2024
  • 1 location
Sequelae of Sars-CoV-2 Infections

By the end of 2019 a new coronavirus, named SARS-CoV-2, was discovered in patients with pneumonia in Wuhan, China. In the following weeks and months the virus spread globally, having a tremendous impact on global health and economy. To date, no vaccine or therapy is available. Severe courses of the …

cardiovascular system
acute respiratory syndrome (sars)
pneumonia
coronavirus infection
  • 0 views
  • 16 Feb, 2024
  • 1 location
Pacing to Maintain Physiologic Ventricular Activation

Right ventricular pacing causes ventricular dyssynchrony and may be associated with impaired outcome. In the last decade, several approaches for more physiological pacing became available and were implemented in the latest guidelines. However, compared to conventional device implantation, cardiac resynchronization, His bundle pacing and left bundle area pacing remain demanding …

cardiac resynchronization therapy
ventricular dyssynchrony
  • 0 views
  • 16 Feb, 2024
  • 1 location